SARS-CoV-2 Variant Characterization and Infectivity Dynamics

SARS-CoV-2 has diversified rapidly since its emergence, spawning multiple lineages defined by distinct mutations in the spike glycoprotein and elsewhere in the genome. Characterisation of these variants draws on genomic surveillance, structural biology, and a range of in vitro and in vivo infectivity assays to link specific mutations with changes in receptor engagement, entry efficiency, replication kinetics and transmission potential. Variants of concern have been identified on the basis of enhanced transmissibility, immune evasion or altered pathogenicity. Functional studies reveal that positive selection is concentrated in the receptor-binding domain of the spike protein, driving adaptations that may increase viral fitness. At the same time, many recurrent mutations appear to exert neutral effects. Improved multiplex and competitive-growth assays now permit rapid genotyping of circulating lineages and quantitative comparison of infectivity dynamics. A thorough understanding of genotype–phenotype relationships remains essential for refining vaccine design, guiding therapeutic strategies and anticipating future waves of viral spread.

Research from Nature Portfolio

Recent studies have examined the impact of the widespread D614G spike substitution on viral infectivity. One investigation showed that the G614 variant assembles more spike trimers per virion, reduces premature shedding of the S1 subunit and enters ACE2-expressing cells with greater efficiency, while preserving sensitivity to neutralising antibodies. A complementary structural and phylogenetic analysis traced the emergence of this substitution as a dominant clade early in the pandemic, concluding that it is largely neutral to receptor-binding affinity but enhances particle stability. In contrast, a broad assessment of recurrent homoplasies across tens of thousands of genomes found no evidence that any independent mutation besides D614G significantly increases transmissibility. Together, these works illustrate how a single spike change can profoundly influence infectivity, while emphasising that most recurrent changes remain evolutionarily neutral.

Research from all publishers

Evolutionary analyses extending beyond SARS-CoV-2 have highlighted positive selection in the S1 region of diverse coronaviruses, with SARS-CoV-2 showing especially strong signals in the receptor-binding domain, likely driven by host shifts and immune pressure. Functional assays employing recombinant reporter viruses with variant spikes have further delineated infectivity phenotypes: the Delta spike confers a clear replication and competitive-fitness advantage over the ancestral backbone, whereas the Omicron BA.1 spike yields reduced viral loads and a less efficient spread in human airway models. These complementary approaches underscore the spectrum of infectivity dynamics among emerging variants and inform risk assessments for future lineages.

SARS-CoV-2 Variant Characterization and Infectivity Dynamics publication trend

The graph below shows the total number of articles in sars-cov-2 variant characterization and infectivity dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Spike protein: Viral surface glycoprotein that mediates attachment to the ACE2 receptor and drives fusion with the host cell membrane.

Receptor-binding domain: Region of the spike protein that directly engages the host receptor, determining host range and entry efficiency.

Variant of concern: A SARS-CoV-2 lineage with mutations linked to increased transmissibility, disease severity or immune escape.

Homoplasy: A genetic change that arises independently in separate viral lineages rather than by descent from a common ancestor.

Pseudovirus: An engineered viral particle bearing a target envelope protein, used to measure viral entry under safe laboratory conditions.

References

1. Adaptive Evolution of the Spike Protein in Coronaviruses. Molecular Biology and Evolution (2023).
2. Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay. Biosensors (2023).
3. Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System. International Journal of Molecular Sciences (2023).
4. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nature Communications (2020).
5. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nature Communications (2020).
6. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide. Scientific Reports (2020).